acromion GmbH   Report issue

For profit Phase 2 Phase 4
Founded: Cologne Germany (2002)
Status: No NME R&D (2002)

Organization Overview

First Clinical Trial
2004
NCT00911807
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

cenegermin-bkbj (oxervate) (1 trial)

sodium chloride (1 trial)

Drugs in Phase 2 Trials (2)

cerebrolysin (1 trial)

donepezil (aricept) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 2)

Dementia (Phase 4)

Dementia, Vascular (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 4